These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 11922209

  • 1. New bone-seeking agent: animal study of Tc-99m-incadronate.
    Shigematsu M, Shomi S, Iwao H, Ochi H.
    Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
    [Abstract] [Full Text] [Related]

  • 2. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA.
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [Abstract] [Full Text] [Related]

  • 3. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V, Kumar D, Howman-Giles RB, Little DG.
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
    Ogawa K, Mukai T, Inoue Y, Ono M, Saji H.
    J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Dec; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 10. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden JL, Green AM, Verbeke K.
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [Abstract] [Full Text] [Related]

  • 11. A new bisphosphonate-containing (99m)Tc(I) tricarbonyl complex potentially useful as bone-seeking agent: synthesis and biological evaluation.
    Palma E, Oliveira BL, Correia JD, Gano L, Maria L, Santos IC, Santos I.
    J Biol Inorg Chem; 2007 Jun; 12(5):667-79. PubMed ID: 17333301
    [Abstract] [Full Text] [Related]

  • 12. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
    Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N.
    J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
    [Abstract] [Full Text] [Related]

  • 13. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
    Ghiron J, Volkert WA, Garlich J, Holmes RA.
    Int J Rad Appl Instrum B; 1991 Jan; 18(2):235-40. PubMed ID: 2026500
    [Abstract] [Full Text] [Related]

  • 14. The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m.
    Asikoglu M, Durak FG.
    Appl Radiat Isot; 2009 Sep; 67(9):1616-21. PubMed ID: 19457677
    [Abstract] [Full Text] [Related]

  • 15. 99mTc-zolmitriptan: radiolabeling, molecular modeling, biodistribution and gamma scintigraphy as a hopeful radiopharmaceutical for lung nuclear imaging.
    Rashed HM, Marzook FA, Farag H.
    Radiol Med; 2016 Dec; 121(12):935-943. PubMed ID: 27586132
    [Abstract] [Full Text] [Related]

  • 16. A novel (99m)Tc-labeled diphosphonic acid as potential bone seeking agent: synthesis and biological evaluation.
    Qiu L, Cheng W, Lin J, Zhang S, Luo S.
    Curr Radiopharm; 2013 Mar; 6(1):28-35. PubMed ID: 23256753
    [Abstract] [Full Text] [Related]

  • 17. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
    Blake GM, Moore AE, Fogelman I.
    Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
    Suzuki K, Satake M, Suwada J, Oshikiri S, Ashino H, Dozono H, Hino A, Kasahara H, Minamizawa T.
    Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
    [Abstract] [Full Text] [Related]

  • 19. [A new radiopharmaceutical for bone imaging: experimental study of 99mTc-HEDTMP].
    Hu S, Deng H, Jiang S, Luo S, Lei Y.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):811-5. PubMed ID: 20842850
    [Abstract] [Full Text] [Related]

  • 20. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK, Blom J, Camps JA, Hermans J, Rijke AM.
    Eur J Nucl Med; 1983 Aug; 8(3):118-22. PubMed ID: 6220908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.